Beryl Drugs Ltd - BERYL DRUGS Share Price

Sector: Pharmaceuticals | ISIN: INE415H01017

Trade

Beryl Drugs Ltd Corporate Actions

31 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Oct , 2023

12:00 AM

Results

View Details

25 Aug , 2023

12:00 AM

AGM

Announcement date: 25 Aug , 2023

View Details

17 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Aug , 2023

12:00 AM

Results

View Details

18 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Feb , 2023

12:00 AM

Results

View Details

25 Aug , 2023

12:00 AM

BookCloser

View Details

Beryl Drugs Ltd News and Update

Zydus Lifesciences Surges 2% as US FDA Grants Final Approval for Heart Drug Ivabradine

01 December, 2023 |
10:07 PM

Zydus Lifesciences will manufacture the drug at its formulation facility in Ahmedabad.

Residential properties owned by PC Jewellers Ltd promoters are taken over b...

IIFL News Service |
30 November, 2023 |
10:05 PM

Aster DM divests stake in Gulf business for $1 billion

IIFL News Service |
29 November, 2023 |
10:03 PM

NTPC Rewards Investors with First Interim Dividend of Rs 2,182 Crore for FY...

IIFL News Service |
24 November, 2023 |
9:56 PM

Beryl Drugs Ltd FINANCIALS

No Data Available To Display Chart

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Beryl Drugs Ltd PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	1,231.25	77.34	2,95,418.12	888.63	0.93	5,019.54	100.23
Divis Laboratories Ltd	3,792.35	76.44	1,00,674.98	342.00	0.79	1,868.00	474.52
Cipla Ltd	1,206.65	31.80	97,418.94	1,029.69	0.70	4,166.74	320.58
Dr Reddys Laboratories Ltd	5,747.40	25.04	95,866.76	1,192.60	0.70	4,819.10	1,362.00
Torrent Pharmaceuticals Ltd	2,151.30	66.01	72,809.77	327.00	1.02	2,115.00	202.85

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

Beryl Drugs Ltd - BERYL DRUGS Share Price

Beryl Drugs Ltd KEY RATIOS

Beryl Drugs Ltd Corporate Actions

Beryl Drugs Ltd News and Update

Zydus Lifesciences Surges 2% as US FDA Grants Final Approval for Heart Drug Ivabradine

Knowledge Center

Beryl Drugs Ltd SHAREHOLDING SNAPSHOT
03 December , 2023 | 11:18 PM

Beryl Drugs Ltd FINANCIALS

Select Period:

QuickLinks for Beryl Drugs Ltd.

Beryl Drugs Information

Beryl Drugs Financials

Beryl Drugs Results

Beryl Drugs News

Beryl Drugs Ltd PEER COMPARISON

MORE ABOUT Beryl Drugs Ltd

Summary

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

Beryl Drugs Ltd - BERYL DRUGS Share Price

Beryl Drugs Ltd KEY RATIOS

Beryl Drugs Ltd Corporate Actions

Beryl Drugs Ltd News and Update

Zydus Lifesciences Surges 2% as US FDA Grants Final Approval for Heart Drug Ivabradine

Knowledge Center

Beryl Drugs Ltd SHAREHOLDING SNAPSHOT 03 December , 2023 | 11:18 PM

Beryl Drugs Ltd FINANCIALS

Select Period:

QuickLinks for Beryl Drugs Ltd.

Beryl Drugs Information

Beryl Drugs Financials

Beryl Drugs Results

Beryl Drugs News

Beryl Drugs Ltd PEER COMPARISON

MORE ABOUT Beryl Drugs Ltd

Summary

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

Beryl Drugs Ltd SHAREHOLDING SNAPSHOT
03 December , 2023 | 11:18 PM